Mechanisms of constitutive NF-κB activation in human prostate cancer cells.
- Published in:
- Prostate, 2002, v. 52, n. 3, p. 183, doi. 10.1002/pros.10082
- By:
- Publication type:
- Article
Works matching IS 02704137 AND DT 2002 AND VI 52 AND IP 3
Results: 7
1
2
Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: Lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor.
- Published in:
- Prostate, 2002, v. 52, n. 3, p. 173, doi. 10.1002/pros.10105
- By:
- Publication type:
- Article
3
Down-regulation of (IIIb) and (IIIc) isoforms of fibroblast growth factor receptor 2 (FGFR2) is associated with malignant progression in human prostate.
- Published in:
- Prostate, 2002, v. 52, n. 3, p. 245, doi. 10.1002/pros.10104
- By:
- Publication type:
- Article
4
Hormones and prostate cancer: Current perspectives and future directions.
- Published in:
- Prostate, 2002, v. 52, n. 3, p. 213, doi. 10.1002/pros.10108
- By:
- Publication type:
- Article
5
Altered apoptotic gene expression and acquired apoptotic resistance in cadmium-transformed human prostate epithelial cells.
- Published in:
- Prostate, 2002, v. 52, n. 3, p. 236, doi. 10.1002/pros.10106
- By:
- Publication type:
- Article
6
Expression of urocortin mRNA and peptide in the human prostate and in prostatic adenocarcinoma.
- Published in:
- Prostate, 2002, v. 52, n. 3, p. 167, doi. 10.1002/pros.10094
- By:
- Publication type:
- Article
7
Mechanisms of the growth inhibitory effects of the isoflavonoid biochanin A on LNCaP cells and xenografts.
- Published in:
- Prostate, 2002, v. 52, n. 3, p. 201, doi. 10.1002/pros.10100
- By:
- Publication type:
- Article